LC–MS/MS Phenolic Profiling and Antioxidant, Antimicrobial, and Antidiabetic Activities of Caucasian Propolis
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202503377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Deniz Canbolat Gültekin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Aromatic Plants Application and Research Center, Artvin Coruh University, Artvin, Türkiye. Hauptthemen laut MEDLINE: Propolis, Antioxidants, Hypoglycemic Agents, Phenols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Scientific and Technological Research Council of Türkiye (TÜBİTAK).
Abstract (Originalsprache)
Propolis is a natural bee product rich in phenolic and flavonoid compounds and is well known for its remarkable biological properties. In this study, the phenolic compositions of propolis samples collected from various localities in the Caucasus region of Türkiye were characterized using LC–MS/MS, and their antioxidant, antidiabetic, and antibacterial activities were also evaluated. LC–MS/MS analyses identified caffeic acid, ferulic acid, and p‐coumaric acid as the major phenolic acid compounds, while pinocembrin, chrysin, and galangin were determined as the major flavonoid constituents. Overall, these findings indicate that the antioxidant capacity of propolis samples obtained from different regions may be particularly associated with these key phenolic and flavonoid compounds. Consistent with this composition, total phenolic and flavonoid contents ranged from 34.72 to 120.54 mg GAE/g and 6.88 to 47.19 mg QE/g, respectively. The extracts exhibited a relatively high antioxidant capacity, with FRAP values between 60.47 and 311.87 mg TE/g and DPPH IC 50 values ranging from 215.80 to 37.96 µg/mL. Regarding antidiabetic activity, the IC 50 values for α‐amylase and α‐glucosidase inhibition were determined as 5.86–3.47 and 12.22–5.02 mg/mL, respectively, indicating a pronounced antidiabetic potential. Antimicrobial analyses revealed activity against E. faecalis, B. cereus, E. coli, K. pneumoniae , and C. albicans . Overall, this study provides a comprehensive LC–MS/MS‐based phenolic profile of Caucasian propolis and demonstrates its antioxidant properties together with its antidiabetic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Aromatic Plants Application and Research Center, Artvin Coruh University, Artvin, Türkiye.
- Department of Medical Biochemistry, Institute of Health Sciences, Karadeniz Technical University, Trabzon, Türkiye.
- Gulhane Faculty of Pharmacy, Department of Biochemistry, University of Health Sciences, Ankara, Türkiye.
- Department of Biotechnology, Graduate School of Natural and Applied Sciences, Gumushane University, Gumushane, Türkiye.
- Science-Technology Research and Application Center, Artvin Coruh University, Artvin, Türkiye.
- Faculty of Medicine, Department of Medical Biochemistry, Karadeniz Technical University, Trabzon, Türkiye.
ORCID-Profile: İbrahim Turan
Förderung
- Scientific and Technological Research Council of Türkiye (TÜBİTAK)
Zitieren
APA
Gültekin, D. C., Turan, İ., Akmeşe, O., Gültekin, E., Demir, S., & Aliyazicioglu, Y. (2026). LC–MS/MS Phenolic Profiling and Antioxidant, Antimicrobial, and Antidiabetic Activities of Caucasian Propolis. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202503377
Vancouver
Gültekin DC, Turan İ, Akmeşe O, Gültekin E, Demir S, Aliyazicioglu Y. LC–MS/MS Phenolic Profiling and Antioxidant, Antimicrobial, and Antidiabetic Activities of Caucasian Propolis. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202503377
BibTeX
@article{Gltekin2026,
author = {Gültekin, Deniz Canbolat and Turan, İbrahim and Akmeşe, Osman and Gültekin, Ergün and Demir, Selim and Aliyazicioglu, Yüksel},
title = {LC–MS/MS Phenolic Profiling and Antioxidant, Antimicrobial, and Antidiabetic Activities of Caucasian Propolis},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202503377}
}
EUVIMED